Discovery Labs (DSCO) Responds to FDA Over SURFAXIN; Plans Q4 Commercialization

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. HD
9. BJ
10. BABA

Go back to Discovery Labs (DSCO) Responds to FDA Over SURFAXIN; Plans Q4 Commercialization
DISCOVERY LABS (NYSE: DSCO) Delayed: 24.78 +0.02 (0.08%)
Previous Close $24.76    52 Week High $3.86 
Open $24.76    52 Week Low $0.15 
Day High $24.85    P/E N/A 
Day Low $24.75    EPS $-0.84 
Volume 27,273